$23.53
Today
as of Jul 22, 16:51 ET
Last 30 days
Recent Press Releases & News
RBC Capital Adjusts Legend Biotech Price Target to $63 From $64, Maintains Outperform Rating
Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress
Legend Biotech (LEGN) Reports a Complete Response in Five of Six Patients at Its Highest Dose
Overview
52-week range
$16
$45
25% of range
Avg surprise (last 3)
-207.3%
Avg reaction (last 2)
+3.2%
50% positive
Latest IV / EM
69%
EM ±15.8% · $23 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-0.15 | $-0.02 | -650.0% | -114.3% | +10.5% | earnings |
| Mon Aug 11, 2025 | Jun/2025 | $-0.34 | $-0.22 | -54.5% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.07 | $-0.40 | +82.5% | — | -4.0% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 10, 2026 | Jun/2026 | OTHER | $0.12 | -$0.34 | +135.3% |